These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21460298)

  • 1. Drug-device trials for infectious diseases: CDRH perspective.
    Meier KL; Gitterman S
    Clin Infect Dis; 2011 May; 52 Suppl 4():S367-72. PubMed ID: 21460298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of diagnostic tests for infectious diseases: general principles.
    Banoo S; Bell D; Bossuyt P; Herring A; Mabey D; Poole F; Smith PG; Sriram N; Wongsrichanalai C; Linke R; O'Brien R; Perkins M; Cunningham J; Matsoso P; Nathanson CM; Olliaro P; Peeling RW; Ramsay A;
    Nat Rev Microbiol; 2006 Sep; 4(9 Suppl):S21-31. PubMed ID: 17034069
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of meta-analyses of diagnostic tests in infectious diseases.
    Cruciani M; Mengoli C
    Infect Dis Clin North Am; 2009 Jun; 23(2):225-67, Table of Contents. PubMed ID: 19393907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization devices: the Food and Drug Administration's regulatory considerations.
    Moynahan M; Faris OP; Lewis BM
    J Am Coll Cardiol; 2005 Dec; 46(12):2325-8. PubMed ID: 16360066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of infectious diseases--principles and challenges].
    Kimura S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():253-7. PubMed ID: 17455626
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of diagnostic tests for infectious diseases: general principles.
    ; Banoo S; Bell D; Bossuyt P; Herring A; Mabey D; Poole F; Smith PG; Sriram N; Wongsrichanalai C; Linke R; O'Brien R; Perkins M
    Nat Rev Microbiol; 2008 Nov; 6(11 Suppl):S16-26. PubMed ID: 22745954
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial designs for predictive marker validation in cancer treatment trials.
    Sargent DJ; Conley BA; Allegra C; Collette L
    J Clin Oncol; 2005 Mar; 23(9):2020-7. PubMed ID: 15774793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guide for diagnostic evaluations.
    Peeling RW; Smith PG; Bossuyt PM
    Nat Rev Microbiol; 2006 Dec; 4(12 Suppl):S2-6. PubMed ID: 17110921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive clinical trials for new drug applications in Japan.
    Ando Y; Hirakawa A; Uyama Y
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):175-9. PubMed ID: 20961739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies for treating infectious diseases].
    Klinguer-Hamour C; Caussanel V; Beck A
    Med Sci (Paris); 2009 Dec; 25(12):1116-20. PubMed ID: 20035689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of clinical trials.
    Rollo D; Machado S; Ceschin M
    Semin Nucl Med; 2010 Sep; 40(5):332-7. PubMed ID: 20674592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in the design of clinical trials for safety in HIV-infected children.
    Lindsey JC; Kline MW
    Pediatr AIDS HIV Infect; 1996 Apr; 7(2):69-82. PubMed ID: 11361484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness considerations for clinical studies of visual prosthetic devices.
    Cohen ED
    J Neural Eng; 2007 Mar; 4(1):S124-9. PubMed ID: 17325410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient safety and efficacy as measured by clinical trials and regulatory policy.
    Harvey BE; Alpert S
    Stud Health Technol Inform; 1997; 39():75-9. PubMed ID: 10168957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with reviewing Bayesian medical device trials.
    Pennello G; Thompson L
    J Biopharm Stat; 2008; 18(1):81-115. PubMed ID: 18161543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A guide for diagnostic evaluations.
    Peeling RW; Smith PG; Bossuyt PM
    Nat Rev Microbiol; 2006 Sep; 4(9 Suppl):S2-6. PubMed ID: 17003769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A better pathway to approval of 21st century cures?
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2017 Feb; 17(2):117. PubMed ID: 28134099
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.